The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
A multistakeholder approach to innovations in NAFLD care
Commun Med (Lond)\. 2023 Jan 3;3(1):1. doi: 10.1038/s43856-022-00228-y.
1Metabolic Liver Research Program, I. Department of Medicine, University Medical Center, Mainz, Germany.
2Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
3Department of Primary Care, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
4School of Public Health, University of Haifa, Haifa, Israel.
5Department of Gastroenterology, Tel-Aviv Medical Center, Tel-Aviv, Israel.
6Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, FL, USA.
7Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, United Kingdom.
8Univ Lyon, CarMen Laboratory, INSERM, INRA, INSA Lyon, Université Claude Bernard Lyon, Pierre-Bénite, France.
9Hospices Civils de Lyon, Département Endocrinologie, Diabète et Nutrition, Hôpital Lyon Sud, Pierre-Bénite, France.
10Department of Gastroenterology Hepatology, Antwerp University Hospital, Edegem, Belgium.
11InflaMed Centre of Excellence, Laboratory for Experimental Medicine and Paediatrics, Translational Sciences in Inflammation and Immunology, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.
12Center for Liver Disease, Inova Medicine, Falls Church, VA, USA.
13Fatty Liver Program, Arizona Liver Health, Phoenix, AZ, USA.
14Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain. Jeffrey.Lazarus@ISGlobal.org.
15CUNY Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, USA. Jeffrey.Lazarus@ISGlobal.org.
16Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain. Jeffrey.Lazarus@ISGlobal.org.
Abstract
Non-alcoholic fatty liver disease (NAFLD) is highly prevalent globally and requires multidisciplinary care. Here, we report key findings of a NAFLD care workshop, address knowledge gaps and highlight a path to optimise healthcare resource use, to improve outcomes in patients with steatotic liver disease.